Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PAPA CABG: Aspirin and Clopidogrel in CABG
NCT00330772Phase 3Completed
- Sponsor
- Hamilton Health Sciences
- Start
- Jul 2006
- Primary completion
- Jun 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of clopidogrel in coronary artery disease (CAD), sponsored by Hamilton Health Sciences. Started Jul 2006; status: completed.
02
Drugs
clopidogrel
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00330772.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00330772.